Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
630.00    -3.00 (-0.47%)
Bid:
630.00
Ask:
641.00
Spread: 11.00 (1.746%)
Market Cap: £551.50m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Directorate Change

29 Sep 2015 16:19

RNS Number : 6078A
Victrex PLC
29 September 2015
 



29 September 2015

Victrex plc - Directorate Change

 

Notification in accordance with Listing Rule 9.6.11R

 

Directorate Change

Victrex plc today announces that Giles Kerr will stand down from the Board as Non-executive Director of Victrex plc and Chairman of the Audit Committee, effective 30 September 2015 after 9 years' service.

Andrew Dougal, an existing Non-executive Director of the Board, will become Chairman of the Audit Committee, effective 1 October 2015.

Enquiries

Victrex plc

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 7809 595831

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions focused on the strategic markets of Automotive, Aerospace, Electronics, Energy and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are delivering leading edge solutions to shape future performance for our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEASNNAFXSEFF
Date   Source Headline
16th Dec 20154:37 pmRNSDirector/PDMR Shareholding
15th Dec 201512:03 pmRNSDirector/PDMR Shareholding
9th Dec 20152:34 pmRNSDirector/PDMR Shareholding
8th Dec 20154:43 pmRNSHolding(s) in Company
8th Dec 20157:00 amRNSFinal Results
4th Dec 20154:07 pmRNSHolding(s) in Company
1st Dec 20154:49 pmRNSHolding(s) in Company
1st Dec 20152:54 pmRNSBlocklisting Interim Review
30th Nov 20153:39 pmRNSTotal Voting Rights
20th Nov 20154:04 pmRNSHolding(s) in Company
17th Nov 20154:08 pmRNSDirector/PDMR Shareholding
30th Oct 201510:32 amRNSTotal Voting Rights
19th Oct 20153:13 pmRNSDirector/PDMR Shareholding
8th Oct 20157:00 amRNSTrading Statement
30th Sep 20151:56 pmRNSTotal Voting Rights
29th Sep 20154:19 pmRNSDirectorate Change
28th Sep 20154:28 pmRNSDirector/PDMR Shareholding
24th Sep 201511:50 amRNSDirector/PDMR Shareholding
21st Sep 201511:42 amRNSHolding(s) in Company
17th Sep 201511:23 amRNSDirector/PDMR Shareholding
28th Aug 201512:06 pmRNSTotal Voting Rights
26th Aug 20154:24 pmRNSHolding(s) in Company
18th Aug 20152:12 pmRNSDirector/PDMR Shareholding
31st Jul 20154:09 pmRNSTotal Voting Rights
31st Jul 20152:24 pmRNSHolding(s) in Company
31st Jul 201512:08 pmRNSDirectorate Change
21st Jul 20157:00 amRNSInterim Management Statement
20th Jul 20159:58 amRNSDirector/PDMR Shareholding
30th Jun 20153:38 pmRNSTotal Voting Rights
26th Jun 201511:07 amRNSDirector Declaration
17th Jun 20154:06 pmRNSDirector/PDMR Shareholding
1st Jun 20153:52 pmRNSBlocklisting Interim Review
29th May 201510:00 amRNSTotal Voting Rights
26th May 20154:39 pmRNSDirector/PDMR Shareholding
19th May 20153:58 pmRNSDirector/PDMR Shareholding
19th May 20159:52 amRNSVictrex first half pretax profit jumps 10%
19th May 20157:00 amRNSHalf Yearly Report
11th May 20154:31 pmRNSHolding(s) in Company
6th May 20154:34 pmRNSHolding(s) in Company
30th Apr 20152:30 pmRNSTotal Voting Rights
28th Apr 20154:34 pmRNSHolding(s) in Company
21st Apr 20157:00 amRNSCapital Markets Day
20th Apr 20153:23 pmRNSDirector/PDMR Shareholding
9th Apr 20157:00 amRNSTrading Statement
31st Mar 20153:25 pmRNSTotal Voting Rights
26th Mar 20153:20 pmRNSDirectorate Change
23rd Mar 20157:00 amRNSDirectorate Change
19th Mar 20154:32 pmRNSHolding(s) in Company
17th Mar 20152:28 pmRNSDirector/PDMR Shareholding
5th Mar 20157:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.